Japan’s MHLW approves CSL Behring’s Andembry to stop HAE attacks

CSL Behring KK has gained approval from Japan's MHLW to manufacture and market subcutaneous injection 200mg Andembry pens.

Feb 21, 2025 - 06:00

Japan’s MHLW approves CSL Behring’s Andembry to stop HAE attacks

CSL Behring KK has gained approval from Japan's MHLW to manufacture and market subcutaneous injection 200mg Andembry pens.

Read the original article

Tags:

Previous Article

Preliminary Research Highlights Potential of University of Utah’s Retinal Surger...

FibroGen sells China unit to AstraZeneca for $160m

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: Neuralink can now study its brain implant in humans, but it’s still catching up to its peers

STAT+: Neuralink can now study its brain implant in hum...

May 27, 2023

EyePoint Pharmaceuticals gets grant for treatment of oc...

May 1, 2024

Listen: ESMO highlights, Roivant’s big deal, & biotech ...

Oct 26, 2023